The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis

Veterinary Journal

Volumn 179, Issue 1, 2009, Pages 10-24

  Sutton, Saski ^a   Clutterbuck, Abigail ^b   Harris, Pat ^c   Gent, Thom ^a   Freeman, Sarah ^b   Foster, Neil ^b   Barrett Jolley, Richard ^a   Mobasheri, Ali ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c WALTHAM CENTRE FOR PET NUTRITION   (United Kingdom)

Author keywords

Cartilage; Corticotropin releasing factor; Growth factors; Interleukins; Nitric oxide; Osteoarthritis; Pro inflammatory cytokines; Prostaglandin E2; Substance P; Synovitis; Synovium; Urocortin; Vasoactive intestinal peptide

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; MATRIX METALLOPROTEINASE; NEUROPEPTIDE; SOMATOMEDIN C; SUBSTANCE P; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UROCORTIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; CARTILAGE DEGENERATION; HUMAN; IMMUNOREACTIVITY; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYNOVITIS; SYNOVIUM;

ANIMALS; CARTILAGE, ARTICULAR; CYTOKINES; DOGS; HORSES; HUMANS; INTERLEUKINS; OSTEOARTHRITIS; SYNOVITIS; TUMOR NECROSIS FACTOR-ALPHA;

CANIS FAMILIARIS; EQUIDAE;

EID: 56849129748     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2007.08.013     Document Type: Review

References (153)

1. Agnello D., Bertini R., Sacco S., Meazza C., Villa P., and Ghezzi P. Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin. American Journal of Physiology 275 (1998) E757-E762
2. Ahmed S., Rahman A., Hasnain A., Goldberg V.M., and Haqqi T.M. Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1. Journal of Pharmacology and Experimental Therapeutics 305 (2003) 981-988
3. Alaaeddine N., Dibattista J.A., Pelletier J.P., Cloutier J.M., Kiansa K., Dupuis M., and Martel-Pelletier J. Osteoarthritic synovial fibroblasts possess an increased level of tumor necrosis factor-receptor 55 (TNF-R55) that mediates biological activation by TNF-alpha. Journal of Rheumatology 24 (1997) 1985-1994
4. Alaaeddine N., Di battista J.A., Pelletier J.P., Kiansa K., Cloutier J.M., and Martel-Pelletier J. Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways. Arthritis and Rheumatism 42 (1999) 710-718
5. Alwan W.H., Carter S.D., Dixon J.B., Bennett D., May S.A., and Edwards G.B. Interleukin-1-like activity in synovial fluids and sera of horses with arthritis. Research in Veterinary Science 51 (1991) 72-77
6. Andriamanalijaona R., Felisaz N., Kim S.J., King-Jones K., Lehmann M., Pujol J.P., and Boumediene K. Mediation of interleukin-1beta-induced transforming growth factor beta1 expression by activator protein 4 transcription factor in primary cultures of bovine articular chondrocytes: possible cooperation with activator protein 1. Arthritis and Rheumatism 48 (2003) 1569-1581
7. Arend W.P., and Dayer J.M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis and Rheumatism 33 (1990) 305-315
8. Bell M.C., and Carroll G.J. Leukaemia inhibitory factor (LIF) suppresses proteoglycan synthesis in porcine and caprine cartilage explants. Cytokine 7 (1995) 137-141
9. Benito M.J., Veale D.J., Fitzgerald O., van den Berg W.B., and Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Annals of the Rheumatic Diseases 64 (2005) 1263-1267
10. Bertolini D.R., Nedwin G.E., Bringman T.S., Smith D.D., and Mundy G.R. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319 (1986) 516-518
11. Beutler B.A. The role of tumor necrosis factor in health and disease. Journal of Rheumatology Supplement 57 (1999) 16-21
12. Billinghurst R.C., Fretz P.B., and Gordon J.R. Induction of intra-articular tumour necrosis factor during acute inflammatory responses in equine arthritis. Equine Veterinary Journal 27 (1995) 208-216
13. Blaney Davidson E.N., Vitters E.L., van der Kraan P.M., and van den Berg W.B. Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation. Annals of the Rheumatic Diseases 65 (2006) 1414-1421
14. Bondeson J., Wainwright S.D., Lauder S., Amos N., and Hughes C.E. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Research Therapy 8 (2006) R187
15. Brama P.A., Tekoppele J.M., Beekman B., van Weeren P.R., and Barneveld A. Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis, and osteochondrosis. Annals of the Rheumatic Diseases 57 (1998) 697-699
16. Brama P.A., Tekoppele J.M., Beekman B., van El B., Barneveld A., and van Weeren P.R. Influence of development and joint pathology on stromelysin enzyme activity in equine synovial fluid. Annals of the Rheumatic Diseases 59 (2000) 155-157
17. Burmester G.R., Dimitriu-Bona A., Waters S.J., and Winchester R.J. Identification of three major synovial lining cell populations by monoclonal antibodies directed to Ia antigens and antigens associated with monocytes/macrophages and fibroblasts. Scandinavian Journal of Immunology 17 (1983) 69-82
18. Caron J.P., Bowker R.M., Abhold R.H., Toppin D.S., Sonea I.M., and Vex K.B. Substance P in the synovial membrane and fluid of the equine middle carpal joint. Equine Veterinary Journal 24 (1992) 364-366
19. Carroll G.J., and Bell M.C. Leukaemia inhibitory factor stimulates proteoglycan resorption in porcine articular cartilage. Rheumatology International 13 (1993) 5-8
20. Carroll G.J., Bell M.C., Chapman H.M., Mills J.N., and Robinson W.F. Leukemia inhibitory factor induces leukocyte infiltration and cartilage proteoglycan degradation in goat joints. Journal of Interferon and Cytokine Research 15 (1995) 567-573
21. Chen F.H., Herndon M.E., Patel N., Hecht J.T., Tuan R.S., and Lawler J. Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. Journal of Biological Chemistry 282 (2007) 24591-24598
22. Cho M.L., Jung Y.O., Moon Y.M., Min S.Y., Yoon C.H., Lee S.H., Park S.H., Cho C.S., Jue D.M., and Kim H.Y. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1-dependent pathways. Immunology Letters 103 (2006) 159-166
23. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New England Journal of Medicine 332 (1995) 1351-1362
24. Chubinskaya S., Hakimiyan A., Pacione C., Yanke A., Rappoport L., Aigner T., Rueger D.C., and Loeser R.F. Synergistic effect of IGF-1 and OP-1 on matrix formation by normal and OA chondrocytes cultured in alginate beads. Osteoarthritis and Cartilage 15 (2007) 421-430
25. Clegg P.D., Burke R.M., Coughlan A.R., Riggs C.M., and Carter S.D. Characterisation of equine matrix metalloproteinase 2 and 9 and identification of the cellular sources of these enzymes in joints. Equine Veterinary Journal 29 (1997) 335-342
26. Clegg P.D., Coughlan A.R., Riggs C.M., and Carter S.D. Matrix metalloproteinases 2 and 9 in equine synovial fluids. Equine Veterinary Journal 29 (1997) 343-348
27. Cope A.P., Gibbons D.L., Aderka D., Foxwell B.M., Wallach D., Maini R.N., Feldmann M., and Brennan F.M. Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cells. Cytokine 5 (1993) 205-212
28. Crofford L.J., Sano H., Karalis K., Webster E.L., Goldmuntz E.A., Chrousos G.P., and Wilder R.L. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. Journal of Clinical Investigation 90 (1992) 2555-2564
29. Crofford L.J., Sano H., Karalis K., Friedman T.C., Epps H.R., Remmers E.F., Mathern P., Chrousos G.P., and Wilder R.L. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. Journal of Immunology 151 (1993) 1587-1596
30. Damiens C., Fortun Y., Charrier C., Heymann D., and Padrines M. Modulation by soluble factors of gelatinase activities released by osteoblastic cells. Cytokine 12 (2000) 1727-1731
31. Darling E.M., and Athanasiou K.A. Growth factor impact on articular cartilage subpopulations. Cell and Tissue Research 322 (2005) 463-473
32. De Clerck L.S., De Gendt C.M., Bridts C.H., van Osselaer N., and Stevens W.J. Expression of neutrophil activation markers and neutrophil adhesion to chondrocytes in rheumatoid arthritis patients: relationship with disease activity. Research in Immunology 146 (1995) 81-87
33. De Grauw J.C., van de Lest C.H., van Weeren R., Brommer H., and Brama P.A. Arthrogenic lameness of the fetlock: synovial fluid markers of inflammation and cartilage turnover in relation to clinical joint pain. Equine Veterinary Journal 38 (2006) 305-311
34. Dechanet J., Taupin J.L., Chomarat P., Rissoan M.C., Moreau J.F., Banchereau J., and Miossec P. Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. European Journal of Immunology 24 (1994) 3222-3228
35. Delgado M., Leceta J., Gomariz R.P., and Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression. Journal of Immunology 163 (1999) 3629-3635
36. Delgado M., Abad C., Martinez C., Leceta J., and Gomariz R.P. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nature Medicine 7 (2001) 563-568
37. Delgado M., Pozo D., and Ganea D. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacological Reviews 56 (2004) 249-290
38. Donaldson L.F., Harmar A.J., Mcqueen D.S., and Seckl J.R. Increased expression of preprotachykinin, calcitonin gene-related peptide, but not vasoactive intestinal peptide messenger RNA in dorsal root ganglia during the development of adjuvant monoarthritis in the rat. Brain Research. Molecular Brain Research 16 (1992) 143-149
39. Dudhia J. Aggrecan, aging and assembly in articular cartilage. Cellular and Molecular Life Sciences 62 (2005) 2241-2256
40. Endo H., Akahoshi T., Nishimura A., Tonegawa M., Takagishi K., Kashiwazaki S., Matsushima K., and Kondo H. Experimental arthritis induced by continuous infusion of IL-8 into rabbit knee joints. Clinical and Experimental Immunology 96 (1994) 31-35
41. Essner R., Rhoades K., Mcbride W.H., Morton D.L., and Economou J.S. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. Journal of Immunology 142 (1989) 3857-3861
42. Fahmi H., Di Battista J.A., Pelletier J.P., Mineau F., Ranger P., and Martel-Pelletier J. Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Arthritis and Rheumatism 44 (2001) 595-607
43. Fell H.B., and Jubb R.W. The effect of synovial tissue on the breakdown of articular cartilage in organ culture. Arthritis and Rheumatism 20 (1977) 1359-1371
44. Fernandez-Madrid F., Karvonen R.L., Teitge R.A., Miller P.R., and Negendank W.G. MR features of osteoarthritis of the knee. Magnetic Resonance Imaging 12 (1994) 703-709
45. Fernandez-Madrid F., Karvonen R.L., Teitge R.A., Miller P.R., An T., and Negendank W.G. Synovial thickening detected by MR imaging in osteoarthritis of the knee confirmed by biopsy as synovitis. Magnetic Resonance Imaging 13 (1995) 177-183
46. Fernandez-martinez A.B., Collado B., Bajo A.M., Sanchez-chapado M., Prieto J.C., and Carmena M.J. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappaB in human prostate cell lines Differential time-dependent responses in cancer progression. Molecular and Cellular Endocrinology 270 (2007) 8-16
47. Fiorito S., Magrini L., Adrey J., Mailhe D., and Brouty-Boye D. Inflammatory status and cartilage regenerative potential of synovial fibroblasts from patients with osteoarthritis and chondropathy. Rheumatology (Oxford) 44 (2005) 164-171
48. Flannery C.R., Little C.B., Hughes C.E., Curtis C.L., Caterson B., and Jones S.A. IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage. Matrix Biology 19 (2000) 549-553
49. Foey A.D., Field S., Ahmed S., Jain A., Feldmann M., Brennan F.M., and Williams R. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis. Arthritis Research and Therapy 5 (2003) R317-R328
50. Fortier L.A., and Nixon A.J. Distributional changes in substance P nociceptive fiber patterns in naturally osteoarthritic articulations. Journal of Rheumatology 24 (1997) 524-530
51. Foster N., Hulme S.D., and Barrow P.A. Induction of antimicrobial pathways during early-phase immune response to Salmonella spp. in murine macrophages: gamma interferon (IFN-gamma) and upregulation of IFN-gamma receptor alpha expression are required for NADPH phagocytic oxidase gp91-stimulated oxidative burst and control of virulent Salmonella spp. Infection and Immunity 71 (2003) 4733-4741
52. Foster N., Cheetham J., Taylor J.J., and Preshaw P.M. VIP Inhibits Porphyromonas gingivalis LPS-induced immune responses in human monocytes. Journal of Dental Research 84 (2005) 999-1004
53. Foster N., Hulme S.D., and Barrow P.A. Inhibition of IFN-gamma-stimulated proinflammatory cytokines by vasoactive intestinal peptide (VIP) correlates with increased survival of Salmonella enterica serovar typhimurium phoP in murine macrophages. Journal of Interferon and Cytokine Research 25 (2005) 31-42
54. Foster N., Hulme S.D., and Barrow P.A. Vasoactive intestinal peptide (VIP) prevents killing of virulent and phoP mutant Salmonella typhimurium by inhibiting IFN-gamma stimulated NADPH oxidative pathways in murine macrophages. Cytokine 36 (2006) 134-140
55. Foster N., Lea S.R., Preshaw P.M., and Taylor J.J. Pivotal advance: vasoactive intestinal peptide inhibits up-regulation of human monocyte TLR2 and TLR4 by LPS and differentiation of monocytes to macrophages. Journal of Leukocyte Biology 81 (2007) 893-903
56. Gomariz R.P., Arranz A., Abad C., Torroba M., Martinez C., Rosignoli F., Garcia-Gomez M., Leceta J., and Juarranz Y. Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP. Journal of Leukocyte Biology 78 (2005) 491-502
57. Gonzalez-Rey E., Chorny A., Fernandez-Martin A., Varela N., and Delgado M. Vasoactive intestinal peptide family as a therapeutic target for Parkinson's disease. Expert Opinion on Therapeutic Targets 9 (2005) 923-929
58. Goodstone N.J., and Hardingham T.E. Tumour necrosis factor alpha stimulates nitric oxide production more potently than interleukin-1beta in porcine articular chondrocytes. Rheumatology (Oxford) 41 (2002) 883-891
59. Gracie J.A., Forsey R.J., Chan W.L., Gilmour A., Leung B.P., Greer M.R., Kennedy K., Carter R., Wei X.Q., Xu D., Field M., Foulis A., Liew F.Y., and Mcinnes I.B. A proinflammatory role for IL-18 in rheumatoid arthritis. Journal of Clinical Investigation 104 (1999) 1393-1401
60. Gronblad M., Konttinen Y.T., Korkala O., Liesi P., Hukkanen M., and Polak J.M. Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. Journal of Rheumatology 15 (1988) 1807-1810
61. Gutierrez-Canas I., Juarranz Y., Santiago B., Arranz A., Martinez C., Galindo M., Paya M., Gomariz R.P., and Pablos J.L. VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts. Rheumatology (Oxford) 45 (2006) 527-532
62. Halliday D.A., Mcneil J.D., Betts W.H., and Scicchitano R. A role for the C-terminal fragment of substance P, SP7-11 in the pathogenesis of arthritis. Regulatory Peptides 46 (1993) 195-197
63. 2+ and collagenase production in bovine articular chondrocytes. Biochemical Journal 292 Pt 1 (1993) 57-62
64. Halliday D.A., Mcneil J.D., and Scicchitano R. A metabolite of substance P, SP7-11 is involved in the pathogenesis of inflammatory joint disease. Medical Hypotheses 40 (1993) 227-231
65. Hart P.H., Ahern M.J., Smith M.D., and Finlay-Jones J.J. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Immunology 84 (1995) 536-542
66. Harvey A.K., Hrubey P.S., and Chandrasekhar S. Transforming growth factor-beta inhibition of interleukin-1 activity involves down-regulation of interleukin-1 receptors on chondrocytes. Experimental Cell Research 195 (1991) 376-385
67. Haupt J.L., Frisbie D.D., Mcilwraith C.W., Robbins P.D., Ghivizzani S., Evans C.H., and Nixon A.J. Dual transduction of insulin-like growth factor-I and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model. Journal of Orthopaedic Research 23 (2005) 118-126
68. Hawkins D.L., Mackay R.J., Gum G.G., Colahan P.T., and Meyer J.C. Effects of intra-articularly administered endotoxin on clinical signs of disease and synovial fluid tumor necrosis factor, interleukin 6, and prostaglandin E2 values in horses. American Journal of Veterinary Research 54 (1993) 379-386
69. Henrotin Y.E., De Groote D.D., Labasse A.H., Gaspar S.E., Zheng S.X., Geenen V.G., and Reginster J.Y. Effects of exogenous IL-1 beta, TNF alpha, IL-6, IL-8 and LIF on cytokine production by human articular chondrocytes. Osteoarthritis and Cartilage 4 (1996) 163-173
70. Henrotin Y., Sanchez C., and Balligand M. Pharmaceutical and nutraceutical management of canine osteoarthritis: present and future perspectives. The Veterinary Journal 170 (2005) 113-123
71. Hernanz A., Medina S., De Miguel E., and Martin-Mola E. Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and osteoarthritis patients. Regulatory Peptides 115 (2003) 19-24
72. Honorati M.C., Cattini L., and Facchini A. IL-17, IL-1beta and TNF-alpha stimulate VEGF production by dedifferentiated chondrocytes. Osteoarthritis and Cartilage 12 (2004) 683-691
73. Honorati M.C., Neri S., Cattini L., and Facchini A. Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthritis and Cartilage 14 (2006) 345-352
74. Horner A., Kemp P., Summers C., Bord S., Bishop N.J., Kelsall A.W., Coleman N., and Compston J.E. Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. Bone 23 (1998) 95-102
75. Hulth A., Johnell O., Miyazono K., Lindberg L., Heinegard D., and Heldin C.H. Effect of transforming growth factor-beta and platelet-derived growth factor-BB on articular cartilage in rats. Journal of Orthopaedic Research 14 (1996) 547-553
76. Hutton C.W., Hinton C., and Dieppe P.A. Intra-articular variation of synovial changes in knee arthritis: biopsy study comparing changes in patellofemoral synovium and the medial tibiofemoral synovium. British Journal of Rheumatology 26 (1987) 5-8
77. Im H.J., Pacione C., Chubinskaya S., van Wijnen A.J., Sun Y., and Loeser R.F. Inhibitory effects of insulin-like growth factor-1 and osteogenic protein-1 on fibronectin fragment- and interleukin-1beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes. Journal of Biological Chemistry 278 (2003) 25386-25394
78. Iwanaga T., Shikichi M., Kitamura H., Yanase H., and Nozawa-Inoue K. Morphology and functional roles of synoviocytes in the joint. Archives of Histology and Cytology 63 (2000) 17-31
79. Izumisawa Y., Yamaguchi M., Bertone A.L., Tangkawattana P., Masty J., Yamashita K., and Kotani T. Equine synovial villi: distinctive structural organization of vasculature and novel nerve endings. Journal of Veterinary Medical Science 58 (1996) 1193-1204
80. Jikko A., Wakisaka T., Iwamoto M., Hiranuma H., Kato Y., Maeda T., Fujishita M., and Fuchihata H. Effects of interleukin-6 on proliferation and proteoglycan metabolism in articular chondrocyte cultures. Cell Biology International 22 (1998) 615-621
81. John T., Kohl B., Mobasheri A., Ertel W., and Shakibaei M. Interleukin-18 induces apoptosis in human articular chondrocytes. Histology and Histopathology 22 (2007) 469-482
82. Jovanovic D., Pelletier J.P., Alaaeddine N., Mineau F., Geng C., Ranger P., and Martel-Pelletier J. Effect of IL-13 on cytokines, cytokine receptors and inhibitors on human osteoarthritis synovium and synovial fibroblasts. Osteoarthritis and Cartilage 6 (1998) 40-49
83. Juarranz Y., Abad C., Martinez C., Arranz A., Gutierrez-Canas I., Rosignoli F., Gomariz R.P., and Leceta J. Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Research and Therapy 7 (2005) R1034-R1045
84. Karalis K., Sano H., Redwine J., Listwak S., Wilder R.L., and Chrousos G.P. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254 (1991) 421-423
85. Kirker-Head C.A., Chandna V.K., Agarwal R.K., Morris E.A., Tidwell A., O'callaghan M.W., Rand W., and Kumar M.S. Concentrations of substance P and prostaglandin E2 in synovial fluid of normal and abnormal joints of horses. American Journal of Veterinary Research 61 (2000) 714-718
86. Kohno M., Kawahito Y., Tsubouchi Y., Hashiramoto A., Yamada R., Inoue K.I., Kusaka Y., Kubo T., Elenkov I.J., Chrousos G.P., Kondo M., and Sano H. Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. Journal of Clinical Endocrinology and Metabolism 86 (2001) 4344-4352
87. Koopman W. Arthritis and Allied Conditions. 14th ed. A Textbook of Rheumatology vol. 2 (2001), Lippincott Williams and Wilkins, Philadelphia pp. 2167-2209
88. Kumar S., Votta B.J., Rieman D.J., Badger A.M., Gowen M., and Lee J.C. IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase. Journal of Cell Physiology 187 (2001) 294-303
89. Lafyatis R., Remmers E.F., Roberts A.B., Yocum D.E., Sporn M.B., and Wilder R.L. Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. Journal of Clinical Investigation 83 (1989) 1267-1276
90. Lam F.Y., and Ferrell W.R. Acute inflammation in the rat knee joint attenuates sympathetic vasoconstriction but enhances neuropeptide-mediated vasodilatation assessed by laser Doppler perfusion imaging. Neuroscience 52 (1993) 443-449
91. Lees P. Pharmacology of drugs used to treat osteoarthritis in veterinary practice. Inflammopharmacology 11 (2003) 385-399
92. Leonard E.J., and Yoshimura T. Neutrophil attractant/activation protein-1(NAP-1 [interleukin-8]). American Journal of Respiratory Cell and Molecular Biology 2 (1990) 479-486
93. Leu S.J., and Singh V.K. Stimulation of interleukin-6 production by corticotropin-releasing factor. Cellular Immunology 143 (1992) 220-227
94. Leung B.P., Mcinnes I.B., Esfandiari E., Wei X.Q., and Liew F.Y. Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis. Journal of Immunology 164 (2000) 6495-6502
95. Levine J.D., Clark R., Devor M., Helms C., Moskowitz M.A., and Basbaum A.I. Intraneuronal substance P contributes to the severity of experimental arthritis. Science 226 (1984) 547-549
96. Lindblad S., and Hedfors E. Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis. Arthritis and Rheumatism 30 (1987) 1081-1088
97. Lisignoli G., Toneguzzi S., Pozzi C., Piacentini A., Riccio M., Ferruzzi A., Gualtieri G., and Facchini A. Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritis. Journal of Rheumatology 26 (1999) 791-799
98. Loeser R.F., Pacione C.A., and Chubinskaya S. The combination of insulin-like growth factor 1 and osteogenic protein 1 promotes increased survival of and matrix synthesis by normal and osteoarthritic human articular chondrocytes. Arthritis and Rheumatism 48 (2003) 2188-2196
99. Loeuille D., Chary-Valckenaere I., Champigneulle J., Rat A.C., Toussaint F., Pinzano-Watrin A., Goebel J.C., Mainard D., Blum A., Pourel J., Netter P., and Gillet P. Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity. Arthritis and Rheumatism 52 (2005) 3492-3501
100. Lotz M., Carson D.A., and Vaughan J.H. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 235 (1987) 893-895
101. Lotz M., Kekow J., and Carson D.A. Transforming growth factor-beta and cellular immune responses in synovial fluids. Journal of Immunology 144 (1990) 4189-4194
102. Maor G., Hochberg Z., and Silbermann M. Insulin-like growth factor I accelerates proliferation and differentiation of cartilage progenitor cells in cultures of neonatal mandibular condyles. Acta Endocrinolologica 128 (1993) 56-64
103. Marshall K.W., Chiu B., and Inman R.D. Substance P and arthritis: analysis of plasma and synovial fluid levels. Arthritis and Rheumatism 33 (1990) 87-90
104. Martel-Pelletier J., Alaaeddine N., and Pelletier J.P. Cytokines and their role in the pathophysiology of osteoarthritis. Frontiers and Bioscience 4 (1999) D694-D703
105. Matayoshi T., Goto T., Fukuhara E., Takano H., Kobayashi S., and Takahashi T. Neuropeptide substance P stimulates the formation of osteoclasts via synovial fibroblastic cells. Biochemical and Biophysical Research Communications 327 (2005) 756-764
106. Matsubara T., Spycher M.A., Ruttner J.R., and Fehr K. The ultrastructural localization of fibronectin in the lining layer of rheumatoid arthritis synovium: the synthesis of fibronectin by type B lining cells. Rheumatology International 3 (1983) 75-79
107. Matsumoto T., Tsukazaki T., Enomoto H., Iwasaki K., and Yamashita S. Effects of interleukin-1 beta on insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes. Annals of the Rheumatic Diseases 53 (1994) 128-133
108. Mcdougall J.J., Watkins L., and Li Z. Vasoactive intestinal peptide (VIP) is a modulator of joint pain in a rat model of osteoarthritis. Pain 123 (2006) 98-105
109. Menkes C.J., Renoux M., Laoussadi S., Mauborgne A., Bruxelle J., and Cesselin F. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Journal of Rheumatology 20 (1993) 714-717
110. Merz D., Liu R., Johnson K., and Terkeltaub R. IL-8/CXCL8 and growth-related oncogene alfa/CXCL1 induce chondrocyte hypertrophic differentiation. Journal of Immunology 171 (2003) 4406-4415
111. Mobasheri A., Gent T.C., Womack M.D., Carter S.D., Clegg P.D., and Barrett-Jolley R. Quantitative analysis of voltage-gated potassium currents from primary equine (Equus caballus) and elephant (Loxodonta africana) articular chondrocytes. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 289 (2005) R172-R180
112. Moldovan F., Pelletier J.P., Hambor J., Cloutier J.M., and Martel-Pelletier J. Collagenase-3 (matrix metalloprotease 13) is preferentially localised in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta. Arthritis and Rheumatism 40 (1997) 1653-1661
113. Morris E.A., Mcdonald B.S., Webb A.C., and Rosenwasser L.J. Identification of interleukin-1 in equine osteoarthritic joint effusions. American Journal of Veterinary Research 51 (1990) 59-64
114. Murray R.C., Smith R.K., Henson F.M.D., and Goodship A. The distribution of cartilage oligomeric matrix protein (COMP) in equine carpal articular cartilage and its variation with exercise and cartilage deterioration. The Veterinary Journal 162 (2001) 121-128
115. Nemoto O., Yamada H., Kikuchi T., Shinmei M., Obata K., Sato H., and Seiki M. Suppression of matrix metalloproteinase-3 synthesis by interleukin-4 in human articular chondrocytes. Journal of Rheumatology 24 (1997) 1774-1779
116. Okazaki K., Jingushi S., Ikenoue T., Urabe K., Sakai H., Ohtsuru A., Akino K., Yamashita S., Nomura S., and Iwamoto Y. Expression of insulin-like growth factor I messenger ribonucleic acid in developing osteophytes in murine experimental osteoarthritis and in rats inoculated with growth hormone-secreting tumor. Endocrinology 140 (1999) 4821-4830
117. Olney R.C., Wang J., Sylvester J.E., and Mougey E.B. Growth factor regulation of human growth plate chondrocyte proliferation in vitro. Biochemical and Biophysical Research Communications 317 (2004) 1171-1182
118. Palmer R.M., Hickery M.S., Charles I.G., Moncada S., and Bayliss M.T. Induction of nitric oxide synthase in human chondrocytes. Biochemical and Biophysical Research Communications 193 (1993) 398-405
119. Pearle A.D., Scanzello C.R., George S., Mandl L.A., Dicarlo E.F., Peterson M., Sculco T.P., and Crow M.K. Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis and Cartilage 15 (2007) 516-523
120. Puren A.J., Fantuzzi G., Gu Y., Su M.S., and Dinarello C.A. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. Journal of Clinical Investigation 101 (1998) 711-721
121. Relic B., Guicheux J., Mezin F., Lubberts E., Togninalli D., Garcia I., van den Berg W.B., and Guerne P.A. Il-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis. Journal of Immunology 166 (2001) 2775-2782
122. Roman-Blas J.A., and Jimenez S.A. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis and Cartilage 14 (2006) 839-848
123. Sadouk M.B., Pelletier J.P., Tardif G., Kiansa K., Cloutier J.M., and Martel-Pelletier J. Human synovial fibroblasts coexpress IL-1 receptor type I and type II mRNA. The increased level of the IL-1 receptor in osteoarthritic cells is related to an increased level of the type I receptor. Laboratory Investigation 73 (1995) 347-355
124. Sakai T., Kambe F., Mitsuyama H., Ishiguro N., Kurokouchi K., Takigawa M., Iwata H., and Seo H. Tumor necrosis factor alpha induces expression of genes for matrix degradation in human chondrocyte-like HCS-2/8 cells through activation of NF-kappaB: abrogation of the tumor necrosis factor alpha effect by proteasome inhibitors. Journal of Bone and Mineral Research 16 (2001) 1272-1280
125. Schuerwegh A.J., Dombrecht E.J., Stevens W.J., van Offel J.F., Bridts C.H., and De Clerck L.S. Influence of pro-inflammatory (IL-1 alpha, IL-6, TNF-alpha, IFN-gamma) and anti-inflammatory (IL-4) cytokines on chondrocyte function. Osteoarthritis and Cartilage 11 (2003) 681-687
126. Schulte E., Fisseler-Eckhoff A., and Muller K.M. Differential diagnosis of synovitis. Correlation of arthroscopic-biopsy to clinical findings. Pathologe 15 (1994) 22-27
127. Seguin C.A., and Bernier S.M. TNFalpha suppresses link protein and type II collagen expression in chondrocytes: role of MEK1/2 and NF-kappaB signaling pathways. Journal of Cell Physiology 197 (2003) 356-369
128. Seitz M., Loetscher P., Dewald B., Towbin H., Ceska M., and Baggiolini M. Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes-regulation by IFN-gamma and IL-4. Journal of Immunology 152 (1994) 2060-2065
129. 2+ concentration and inositol phosphate formation. Journal of Immunology 141 (1988) 2118-2124
130. Shalom-Barak T., Quach J., and Lotz M. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. Journal of Biological Chemistry 273 (1998) 27467-27473
131. Shioi A., Teitelbaum S.L., Ross F.P., Welgus H.G., Suzuki H., Ohara J., and Lacey D.L. Interleukin 4 inhibits murine osteoclast formation in vitro. Journal of Cellular Biochemistry 47 (1991) 272-277
132. Singh V.K., and Leu S.J. Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. Neuroscience Letters 120 (1990) 151-154
133. Smith Jr. G.N., Hasty K.A., Yu Jr. L.P., Lamberson K.S., Mickler E.A., and Brandt K.D. Cleavage of type XI collagen fibers by gelatinase and by extracts of osteoarthritic canine cartilage. Matrix 11 (1991) 36-42
134. Smith M.D., Triantafillou S., Parker A., Youssef P.P., and Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. Journal of Rheumatology 24 (1997) 365-371
135. Smith K.J., Bertone A.L., Weisbrode S.E., and Radmacher M. Gross, histologic, and gene expression characteristics of osteoarthritic articular cartilage of the metacarpal condyle of horses. American Journal of Veterinary Research 67 (2006) 1299-1306
136. Spiers S., May S.A., Bennett D., and Edwards G.B. Cellular sources of proteolytic enzymes in equine joints. Equine Veterinary Journal 26 (1994) 43-47
137. Takafuji V.A., Mcilwraith C.W., and Howard R.D. Effects of equine recombinant interleukin-1alpha and interleukin-1beta on proteoglycan metabolism and prostaglandin E2 synthesis in equine articular cartilage explants. American Journal Veterinary Research 63 (2002) 551-558
138. Todhunter P.G., Kincaid S.A., Todhunter R.J., Kammermann J.R., Johnstone B., Baird A.N., Hanson R.R., Wright J.M., Lin H.C., and Purohit R.C. Immunohistochemical analysis of an equine model of synovitis-induced arthritis. American Journal of Veterinary Research 57 (1996) 1080-1093
139. Tsunawaki S., Sporn M., Ding A., and Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature 334 (1988) 260-262
140. Tung J.T., Fenton J.I., Arnold C., Alexander L., Yuzbasiyan-Gurkan V., venta P.J., Peters T.L., Orth M.W., Richardson D.W., and Caron J.P. Recombinant equine interleukin-1beta induces putative mediators of articular cartilage degradation in equine chondrocytes. Canadian Journal of Veterinary Research 66 (2002) 19-25
141. Vachon A.M., Keeley F.W., Mcilwraith C.W., and Chapman P. Biochemical analysis of normal articular cartilage in horses. American Journal of Veterinary Research 51 (1990) 1905-1911
142. van Beuningen H.M., Arntz O.J., and van den Berg W.B. In vivo effects of interleukin-1 on articular cartilage. Prolongation of proteoglycan metabolic disturbances in old mice. Arthritis and Rheumatism 34 (1991) 606-615
143. van Beuningen H.M., Glansbeek H.L., van der Kraan P.M., and van den Berg W.B. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis and Cartilage 8 (2000) 25-33
144. Varghese S., Yu K., and Canalis E. Leukemia inhibitory factor and oncostatin M stimulate collagenase-3 expression in osteoblasts. American Journal of Physiology 276 (1999) E465-E471
145. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378 (1995) 287-292
146. Villiger P.M., Geng Y., and Lotz M. Induction of cytokine expression by leukemia inhibitory factor. Journal of Clinical Investigation 91 (1993) 1575-1581
147. von Rechenberg B., Mcilwraith C.W., Akens M.K., Frisbie D.D., Leutenegger C., and Auer J.A. Spontaneous production of nitric oxide (NO), prostaglandin (PGE2) and neutral metalloproteinases (NMPs) in media of explant cultures of equine synovial membrane and articular cartilage from normal and osteoarthritic joints. Equine Veterinary Journal 32 (2000) 140-150
148. Watanabe H., Yamada Y., and Kimata K. Roles of aggrecan, a large chondroitin sulfate proteoglycan, in cartilage structure and function. Journal of Biochemistry (Tokyo) 124 (1998) 687-693
149. Woods R.J., David J., Baigent S., Gibbins J., and Lowry P.J. Elevated levels of corticotrophin-releasing factor binding protein in the blood of patients suffering from arthritis and septicaemia and the presence of novel ligands in synovial fluid. British Journal of Rheumatology 35 (1996) 120-124
150. Woods J.M., Katschke K.J., Volin M.V., Ruth J.H., Woodruff D.C., Amin M.A., Connors M.A., Kurata H., Arai K., Haines G.K., Kumar P., and Koch A.E. IL-4 adenoviral gene therapy reduces inflammation, proinflammatory cytokines, vascularization, and bony destruction in rat adjuvant-induced arthritis. Journal of Immunology 166 (2001) 1214-1222
151. Yang L., and Fa X.G. The effect of substance P on functional proteins in human neutrophil. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 24 (2002) 98-101
152. Yao Z., Painter S.L., Fanslow W.C., Ulrich D., Macduff B.M., Spriggs M.K., and Armitage R.J. Human IL-17: a novel cytokine derived from T cells. Journal of Immunology 155 (1995) 5483-5486
153. Yu C.L., Sun K.H., Shei S.C., Tsai C.Y., Tsai S.T., Wang J.C., Liao T.S., Lin W.M., Chen H.L., Yu H.S., et al. Interleukin 8 modulates interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha release from normal human mononuclear cells. Immunopharmacology 27 (1994) 207-214